The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year

OBJECTIVE: Infliximab is effective in improving signs and symptoms of joint/skin involvement, functional status, and quality of life in patients with psoriatic arthritis (PsA). Using IMPACT trial data, we assessed the effect of infliximab (IFX) on structural damage in PsA. METHODS: Patients with act...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kavanaugh, A, Antoni, C E, Gladman, D, Wassenberg, S, Zhou, B, Beutler, A, Keenan, G, Burmester, G, Furst, D E, Weisman, M H, Kalden, J R, Smolen, J, van der Heijde, D
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2006
Sujets:
Extended Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798249/
https://ncbi.nlm.nih.gov/pubmed/16439444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.045658
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires